SR ONE CAPITAL MANAGEMENT, LLC bought ZBIO
October 9, 2025 · Form 4 insider transaction
SR ONE CAPITAL MANAGEMENT, LLC bought 63,158 shares of Zenas BioPharma, Inc. at $19.00 per share, a transaction worth $1.20M. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 5 days after the transaction.
Footnotes
Acquired from the Issuer on October 9, 2025 pursuant to a Securities Purchase Agreement dated October 7, 2025.; The reported securities are held directly by SR One Capital Opportunities Fund I, LP. SR One Capital Opportunities Partners I, LP is the general partner of SR One Capital Opportunities Fund I, LP, and SR One Capital Management, LLC is the general partner of SR One Capital Opportunities Partners I, LP. Simeon George, M.D. is the managing member of SR One Capital Management, LLC. Each of SR One Capital Opportunities Partners I, LP, SR One Capital Management, LLC and Dr. George may be deemed to have shared power to vote or dispose of these shares, and each disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein.